Log In
BCIQ
Print this Print this
 

SR-3306

  Manage Alerts
Collapse Summary General Information
Company Opko Health Inc.
DescriptionC-jun N-terminal kinase (JNK) inhibitor
Molecular Target c-jun N-terminal kinase (JNK)
Mechanism of Actionc-jun N-terminal kinase (JNK) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat Parkinson's disease (PD)
Regulatory Designation
PartnerThe Scripps Research Institute

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/09/2012

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today